Performance of a new interference-resistant glucose meter

Clinical Biochemistry

Volumn 43, Issue 1-2, 2010, Pages 186-192

  Vanavanan, Somlak ^a   Santanirand, Pitak ^a   Chaichanajarernkul, Upsorn ^a   Chittamma, Anchalee ^a   DuBois, Jeffrey A ^b   Shirey, Terry ^b   Heinz, Mark ^b  

^a THAMMASAT UNIVERSITY   (Thailand)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Glucose meter; Interference resistant glucose meter; POCT; Point of Care Testing; Self monitoring of blood glucose (SMBG)

Indexed keywords

ASCORBIC ACID; GLUCOSE; HEXOKINASE; MALTOSE; PARACETAMOL;

ACCURACY; ANALYTIC METHOD; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; BLOOD SAMPLING; CONTROLLED STUDY; HEMATOCRIT; HEPARINIZATION; HUMAN; INTERMETHOD COMPARISON; PRIORITY JOURNAL;

ACETAMINOPHEN; ASCORBIC ACID; BIOSENSING TECHNIQUES; BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; HUMANS; MALTOSE; POINT-OF-CARE SYSTEMS; REAGENT STRIPS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 73149112406     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.09.010     Document Type: Article

References (40)

1. American Diabetes Association Position Statement Tests of Glycemia of in Diabetes. Diabetes Care 27 (2004) S91-93
2. Sacks D.B., Bruns D.E., Goldstein D.E., Maclaren N.K., McDonald J.M., and Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin. Chem. 48 (2002) 436-472
3. Winkelman J.W., Wybenga D.R., and Tanasijevic M.J. The fiscal consequences of central vs distributed testing of glucose. Clin. Chem. 40 (1994) 1628-1630
4. Alex C.P., Manto J.C., and Garland J.S. Clinical utility of a bedside blood analyzer for measuring blood chemistry values in neonates. J. Perinatol. 18 (1998) 45-48
5. Titus K. Bedside glucose testing systems. CAP Today 2004;18:22,24,26-22,24,31.
6. American Diabetes Association. Resource guide 2005. Blood glucose meters and data management system. Diabetes Forecast 2005;58:RG36-46, RG49.
7. Ford A. Bedside glucose testing systems. CAP Today 26 (2006) 26-31
8. Sluss P.M. Bedside blood glucose testing systems: current technology. Point Care 5 (2006) 121-125
9. American Diabetes Association. Self-monitoring of diabetes. Diabetes Care 19 (1996) S62-66
10. National Committee for Clinical Laboratory Standards. Point-of-Care Blood-Glucose Testing in Acute and Chronic Care Facilities; Approved Guideline. 2nd ed (2002), NCCLS, Wayne, PA NCCLS document C30-A2
11. Kost G.J., Vu H.T., Lee J.H., et al. Multicenter study of oxygen insensitive handheld glucose point-of-care testing in critical care/hospital/ambulatory patients in the United States and Canada. Crit. Care Med. 26 (1998) 581-590
12. Sinternational Organization for Standardization. In vitro Diagnostic test systems-requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus. ISO 15197:2003 (E) (2003), ISO, Geneva, Switzerland
13. Clarke W.L., Cox D., Goder-Frederick L.A., Carter W., and Pohl S.L. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 10 (1987) 622-628
14. Briggs A.L., and Cornell S. Self-monitoring blood glucose (SMBG): now and the future. J. Pharm. Pract. 17 (2004) 29-38
15. Kilpatrick E.S., Rumley A.G., and Smith A.E. Variations in sample pH and pO2 affect ExacTech meter glucose measurements. Diabet. Med. 11 (1994) 506-509
16. Kost G.J., Vu H.T., Lee J.H., et al. Multicentre study of oxygen-insensitive handheld glucose point-of-care testing in critical care/hospital/ambulatory patients in the United States and Canada. Crit. Care Med. 26 (1998) 581-590
17. Chance J.J., Li D.J., Jones K.A., Dyer K.L., and Nichols J.H. Technical evaluation of five glucose meters with data management capabilities. Am. J. Clin. Pathol. 111 (1999) 547-556
18. Solnica B., Naskalski J.W., and Sieradzki J. The evaluation of analytical performance of the Precision G point-of-care glucometer. Clin. Chem. Lab. Med. 39 (2001) 1283-1286
19. Brunner G.A., Ellmerer M., Sendlhofer G., et al. Validation of home blood glucose meters with respect to clinical and analytical approaches. Diabetes Care 21 (1998) 585-590
20. Soldin S.J., Devairakkam P.D., and Agarwalla P.K. Evaluation of the Abbott PCx-point of care glucose analyzer in a pediatric hospital. Clin. Biochem. 33 (2000) 319-321
21. Skeie S., Thue G., and Sandberg S. Patient-derived quality specifications for instruments used in self-monitoring of blood glucose. Clin. Chem. 47 (2001) 67-73
22. Boyd J.C., and Bruns D.E. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin. Chem. 47 (2001) 209-214
23. Karon B.S., Griesmann L., Scott R., et al. Evaluation of the impact of hematocrit and other interference on the accuracy of hospital-based glucose meter. Diabetes Technol. Ther. 10 (2008) 111-120
24. Dai K.-S., Tai D.-Y., Ho P., et al. Accuracy of the EasyTouch blood glucose self-monitoring system: a study of 516 cases. Clin. Chim. Acta. 349 (2004) 135-141
25. Lippi G., Salvagno G.L., Guidi G.C., Negri M., and Rizzotti P. Evaluation of four portable self-monitoring blood glucose meters. Ann. Clin. Biochem. 43 (2006) 408-413
26. Rheney C.C., and Kirk J.K. Performance of three blood glucose meters. Ann. Pharmacother. 34 (2000) 317-321
27. Weitgasser R., Gappmayer B., and Pichler M. Newer portable glucose meters-analytical improvement compared with previous generation devices?. Clin. Chem. 45 (1999) 1821-1825
28. Poirier J.Y., Le Prieur N., Campion L., Guilhem I., Allannic H., and Maugendre D. Clinical and statistical evaluation of self-monitoring blood glucose meters. Diabetes Care 21 (1998) 1919-1924
29. Moatti-Sirat D., Velho G., and Reach G. Evaluating in vitro and in vivo the interference of ascorbate and acetaminophen on glucose detection by a needletype glucose sensor. Biosens. Bioelectron. 7 (1992) 345-352
30. Louie R.F., Tang Z., Sutton D.V., Lee J.H., and Kost G.J. Point-of-care glucose testing: effects of critical care variables, influence of reference instruments, and a modular glucose meter design. Arch. Pathol. Lab. Med. 124 (2000) 257-266
31. Tang Z., Du X., Louie R.F., and Kost G.J. Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. Am. J. Clin. Pathol. 113 (2000) 75-86
32. Kaufmann-Raab I., Jonen H.G., Jähnchen E., et al. Interference by acetaminophen in the glucose oxidase-peroxidase method for blood glucose determination. Clin. Chem. 22 (1976) 1729-1731
33. Lewis B.D. Laboratory evaluation of the Glucocard (blood glucose test meter. Clin. Chem. 38 (1992) 2093-2095
34. Mayer M., and Salpeter L. Toxic levels of acetaminophen produce a major positive interference on Glucometer Elite and Accu-chek Advantage glucose meters [letter]. Clin. Chem. 44 (1998) 893-894
35. Lindh M., Lindgren K., Carlström A., et al. Electrochemical interferences with the YSI glucose analyzer [letter]. Clin. Chem. 28 (1982) 726
36. Institute for Safe Medication Practices. Be aware of false glucose results with point-of-care testing. ISMP Medication Safety Alert 10 (2005) 13
37. Janssen W., Harff G., Caers M., and Schellekens A. Positive interference of icodextrin metabolites in some enzymatic glucose methods. Clin. Chem. 44 (1998) 2379-2380
38. Kilpatrick E.S., Rumley A.G., and Myin H. The effect of variations in hematocrit, mean cell volume and red blood count on reagent strip tests for glucose. Ann. Clin. Biochem. 30 (1993) 485-487
39. Tang Z., Lee J.H., Louie R.F., and Kost G.J. Effects of different hematocrit levels on glucose measurements with handheld meters for point of care testing. Arch. Pathol. Lab. Med. 124 (2000) 1135-1140
40. Louis P.S., and Ethier J. An evaluation of three glucose meter systems and their performance in relation to criteria of acceptability for neonatal specimens. Clin. Chim. Acta 322 (2002) 139-148